Fundraising FoxLodo Therapeutics
New York, US · Founded 2015 · Delaware corporation · 5 known investors
Find your way into Lodo Therapeutics
Sign up to see every warm intro you have to Lodo Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lodo Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DP
David PomplianoExecutive
DM
David McElligottExecutive
Board
DS
David SchubertBoard director
JM
Joel MarcusBoard directorExecutive Chairman & Founder at Alexandria
LR
Lindsay RayleBoard director
BD
Barbara DaltonBoard director
MJ
M. Johnston ErwinBoard director
MU
TL
Thong LeBoard director
AX
Asish XavierBoard director
JS
James SullivanBoard director
Investors · 5
Pfizer Venture Investmentslisted by Pfizer Venture Investments$5M – $20M
How we know: Pfizer Venture Investments's portfolio page · Not right? Tell us
AbbViereportedCambridge · $300K – $3M
How we know: funding news · Not right? Tell us
AlexandriareportedPasadena
How we know: funding news · Not right? Tell us
ARCH Venture PartnersreportedChicago · $50K – $250M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$19.9M disclosed across 1 round · 2015
▶$19.9MraisedJan 2017 · 13 investors · BiotechnologyRule 506(b)
▶$19.9MraisedJan 2017 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David SchubertExecutive Officer, Promoter
- Joel MarcusDirector
- Lindsay RayleExecutive Officer, Promoter
- Barbara DaltonDirector
- Steve GillisDirector
- David PomplianoExecutive Officer
- M. Johnston ErwinDirector
- Misti UshioDirector
- Thong LeExecutive Officer, Director, Promoter
- David McElligottExecutive Officer, Promoter
- Asish XavierDirector
- James SullivanDirector
- Offering amount
- $19.9M
- Amount sold
- $19.9M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Lodo Therapeutics's investors?
- Lodo Therapeutics's investors include Pfizer Venture Investments, AbbVie, Alexandria, ARCH Venture Partners, Digitalis Ventures.
- How much funding has Lodo Therapeutics raised?
- Lodo Therapeutics has disclosed $19.9M raised across 1 round.
- Where is Lodo Therapeutics headquartered?
- Lodo Therapeutics is headquartered in New York, US.